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Mitochondria provide a critical control point for the
apoptotic route [1]. The intermembrane spaces of these
organelles function as storage compartments for a
number of pro-death proteins, such as cytochrome c,
which are released into the cytoplasm as a consequence
of apoptotic signals. The release of these apoptotic
factors involves alteration of the mitochondrial outer
membrane barrier, and is controlled by members of a
large family of proteins known as B-cell lymphoma
protein 2 (Bcl2) [2].
Bcl2 associated protein X (Bax) is a prototype, pro-
death member of the Bcl2 family [3]. Although this
protein is normally found soluble in the cytoplasm, its
apoptotic activation includes extensive structural reor-
ganization, which facilitates targeting to, and insertion
into, the mitochondrial outer membrane [4–6]. The lat-
ter process is promoted by other types of Bcl2 protein,
exemplified by Bid, that share with the former only the
BH3 domain [7–9]. Proteolitically activated Bid (tBid)
may, in turn, activate Bax through BH3-dependent or
BH3-independent interactions [10]. Once in the mito-
chondrial outer membrane, Bax forms oligomeric
pores and facilitates the release of cytochrome c [9,11].
In vitro, Bax can promote the release of fluorescent
probes and cytochrome c from large unilamellar vesi-
cles (LUVs) [12]. The characteristics of this activity
and the properties of ion channels measured in planar
lipid bilayers [13] led Basañez and coworkers [14] to
propose that Bax forms partially lipid pores. Thus,
the permeabilizing activity of Bax depends on the
curvature properties of the bilayer, being induced by
nonlamellar lipids with positive intrinsic curvature,
but inhibited by lipids with negative intrinsic curva-
ture [10,15]. Other cell-death-related proteins, such as
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Proteins of the B-cell lymphoma protein 2 (Bcl2) family are key regulators
of the apoptotic cascade, controlling the release of apoptotic factors from
the mitochondrial intermembrane space. A helical hairpin found in the core
of water-soluble folds of these proteins has been reported to be the pore-
forming domain. Here we show that peptides including any of the two
a-helix fragments of the hairpin of Bcl2 associated protein X (Bax) can
independently induce release of large labelled dextrans from synthetic lipid
vesicles. The permeability promoted by these peptides is influenced by
intrinsic monolayer curvature and accompanied by fast transbilayer redis-
tribution of lipids, supporting a toroidal pore mechanism as in the case of
the full-length protein. However, compared with the pores made by com-
plete Bax, the pores made by the Bax peptides are smaller and do not need
the concerted action of tBid. These data indicate that the sequences of both
fragments of the hairpin contain the principal physicochemical require-
ments for pore formation, showing a parallel between the permeabilization
mechanism of a complex regulated protein system, such as Bax, and the
much simpler pore-forming antibiotic peptides.
Abbreviations
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colicins [16] and actinoporins [17,18], and helical
antimicrobial peptides, such as magainin [19,20] and
melittin [21], have also been reported to form parti-
ally lipid pores, often described as toroidal because of
their assumed geometry. These structures are thought
to be similar to purely lipid holes, such as those
formed under a number of stress conditions [22], but
with the wall of the pore made of both lipid and pro-
tein molecules. At the rim of the membrane hole, the
two leaflets of the bilayer can make contact with each
other, forming a membrane edge with positive mono-
layer curvature at a plane perpendicular to the bilayer
and negative monolayer curvature in the plane of the
membrane [17,20,23] (Fig. 1). The organization of the
protein or peptide molecules in the pore is not yet
known, but they can be assumed to always lie embed-
ded in the polar surface of the membrane, with vari-
able insertion into the hydrocarbon region [20]. It is
assumed that a number of peptide (or protein)
molecules participate in the architecture of the
supramolecular pore complex, although direct pep-
tide–peptide interactions would in principle not be
required.
The structure of water-soluble forms of a number of
Bcl2 proteins is known (see, for example [24,25]). The
most characteristic feature of this structure is a dou-
ble-helix hairpin buried in the core of the proteins.
This domain has the capacity to bind strongly to lipid
membranes [26] and is regarded as being responsible
for pore formation [27]. In line with this idea, we have
shown recently that a peptide derived from the first
helix of the hairpin of Bax can permeabilize model
membranes, with characteristics that can be ascribed
to the formation of partially lipid pores [28]. In this
paper we describe the permeabilizing activity of a pep-
tide derived from the second helix of the putative
pore-forming domain of Bax. We show that peptides
with the sequence of the first (a5) and second (a6) heli-
ces of the Bax hairpin (Fig. 2) can independently
reproduce important characteristics of the activity of
the full-length parent protein. In both cases, membrane
pores are formed, which are able to export high-
molecular-mass dextrans and are influenced by lipid
spontaneous curvature. Pore formation is accompanied
by lipid redistribution between the bilayer leaflets, sup-
porting the model of a toroidal pore and in good
agreement with the characteristics of the pore formed
by Bax.
Although the individual peptide fragments do not
exhibit the regulatory properties of the full-length par-
ent protein, this work demonstrates the usefulness of
short peptides as simple model systems in helping us
to understand fundamental aspects of complex func-
tional mechanisms.
Results and discussion
Peptides of helices 5 and 6 from Bax are mainly
a-helical in lipid-mimetic environments
The peptides used for this study (Fig. 2) are part of
the characteristic hairpin that is taken as a signature
domain of Bcl-2s and other structurally analogous
pore-forming proteins. They contain the segments that
in the full-length, water-soluble Bax make the fifth and
sixth a-helices of the protein structure [25]. However,
when these fragments are taken out of their protein
context and placed in a lipid environment, an a-helical
structure should not necessarily be assumed. To check
if these peptides indeed arrange themselves into helical





Fig. 1. Schematic representation of the idealized geometry of a
lipid pore and the expected effect of spontaneous curvature of
lipids. The rim of a lipid pore can be represented as a semi-toroidal
surface at the point where the two monolayers fuse. This is charac-
terized by strong curvature stress, caused by inefficient molecular
packing, which causes high line tension and makes the pores ener-
getically unfavourable. Because of the saddle-like geometry at the
rim, both positive curvature, in a plane perpendicular to the mem-
brane, and negative curvature, in the plane of the membrane, are
present. In contrast with cylindrically shaped lipids, such as PtdCho
(PC), lipids with anisotropic, cone-like shapes can improve packing
at the rim and increase the stability of the pore. The latter is the
case for lysolipids, such as lysoPtdCho (LPC), with positive intrinsic
curvature, and the HII phase-inducing lipids, such as PtdEtn (PE),
with negative intrinsic curvature. The positive curvature should
have a dominant effect in most cases, as the negative curvature is
expected to be important only for small pores [23].
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As we can qualitatively appreciate in the CD spectra
of Fig. 3, both peptides already display significant
helicity in aqueous solvent (dotted lines). Under these
conditions, values of  40% total helical structure,
considering both regular and distorted a-helix, are
calculated in the case of Bax-a5 and  20% in the case
of Bax-a6 (Table 1). The presence of even moderate
amounts of SDS (Fig. 3A,C) or trifluoroethanol
(Fig. 3B,D) induces large increases in helical structure.
Thus, 0.5 mm SDS is enough to induce more than
80% a-helix in Bax-a5 and about 50% in the case of
Bax-a6. With 20% trifluoroethanol, Bax-a5 reaches
almost complete helix induction ( 90%), and  42%
of Bax-a6 is found with helical conformation. Further
increases of lipid-mimetic reagents, up to 4 mm SDS





Fig. 2. Part of the sequence of Bcl2 associated protein X (Bax) and the peptides investigated in this work. The fragment from residues 102–
154 of mouse Bax is shown, which includes the a5–a6 hairpin (A), with residues found in a-helix in the structure of the water-soluble form
of the protein [25] highlighted in white over a dark grey background. Aligned are the sequence of the peptide Bax-a5KK (B), studied previ-
ously [28], and the sequences of Bax-a5 (C) and Bax-a6 (D), studied here, with relevant residues highlighted: positively charged residues are
coloured blue, negatively charged residues are coloured red, and residues substituted with respect to the wild-type sequence are printed
over a light grey background.
A B
C D
Fig. 3. CD spectra of Bax-a5 and Bax-a6 in
lipid-mimetic media. CD spectra are shown
for Bax-a5 (A, B) and Bax-a6 (C, D) in pure
aqueous buffer (dotted lines) or in the pres-
ence of different concentrations of SDS
(solid lines, A and C) or trifluoroethanol
(solid lines, B and D). In all samples the pep-
tide was at a concentration of 30 lM, and
the aqueous buffer was 10 mM sodium
phosphate, pH 7.0. The amounts of added
trifluoroethanol (percentage) and SDS
(mMÆL)1) are indicated on the graphs.
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 60% in Bax-a6 (Table 1). Helix induction takes
place with a reduction in turn and unordered random-
coil structures, but especially at the expense of the
b-strand structures, which are practically absent in the
presence of the lipid-mimetic reagents (Table 1).
It is interesting to compare these results with our
previous structural study of a different peptide that
also included the sequence corresponding to a-helix 5
of Bax (Fig. 2B,C) [28], although it was shorter by six
residues at the N-terminus and contained two extra,
non-natural Lys residues, one at each end, compared
with Bax-a5 studied here. For the sake of clarity, we
will refer to the peptide studied previously as Bax-
a5KK. The observed structural consequence of the dif-
ferences between Bax-a5 and Bax-a5KK is a larger
intrinsic tendency of the former to fold into an a-helix.
Thus, for Bax-a5, this type of structure, represented by
the sum of regular and distorted helices (Table 1), is
the most abundant one, even in pure aqueous buffer,
and it dominates in lipid-mimetic media. Bax-a5KK has
also been investigated by Fourier transform infrared-
attenuated total reflection in oriented lipid-bilayer
samples using polarized light [28]. Two distinct types
of a-helix, oriented differently, were found in this case:
one regular type of a-helix was tilted with respect to
the membrane plane, whereas one distorted helix was
laying flat in the membrane. The tilted helical stretch
probably corresponded to the more hydrophobic
N-terminal side of the peptide. This part has been
extended in the case of Bax-a5, which may stabilize
a longer N-terminal helix and explain the increase in
the activity of this peptide version with respect to
Bax-a5KK (see below).
Helices 5 and 6 of Bax independently
permeabilize vesicles, with activities affected by
lipid spontaneous curvature
The peptides encompassing helices 5 and 6 of Bax dis-
play a potent calcein-release activity in LUVs of differ-
ent compositions. The dependence of vesicle poration
on the concentration of the peptides typically yields
sigmoidal curves, indicative of co-operativity, with
inflexion points corresponding to peptide concentra-
tions giving 50% of maximum activity (IC50). With
LUVs made of PtdCho at 6 lm lipid concentration,
IC50 values are in the nanomolar range for Bax-a5
(Fig. 4A, squares and continuous line), and about an
order of magnitude higher for Bax-a6 (Fig. 4B). The
process also depends on the lipid composition of the
vesicles, as summarized in Table 2. For both Bax-a5
and Bax-a6, the activity values, expressed as 1 ⁄ IC50,
are larger in neutral lipid bilayers made of PtdCho
than in the presence of negatively charged lipids such
as PtdSer and cardiolipin. In the case of Bax-a5, which
possess a net positive charge (Fig. 2), we would expect
increased binding to negatively charged membranes,
as observed previously for Bax-a5KK [28]. Thus, it
appears that electrostatic forces exert a negative effect
on the activity of these peptides, probably through
increased binding which favours an inactive state with
the peptide adsorbed at the membrane interface (but
see below).
The poration activity of full-length Bax and Bax-like
proteins is greatly influenced by the intrinsic mono-
layer curvature of the membrane lipids. The presence
of lipids with a positive intrinsic curvature, such as
Table 1. Secondary structure of Bax-a5 and Bax-a6 peptides after analysis of the CD spectra. H, helix; S, strand; Trn, turn; Unrd, unordered;
(r), regular; (d), distorted, as defined by the standard output of CDPro. Mean is the average of the results obtained with CDSSTR, CONTIN/LL
and SELCON3 [42,43], and SD is the standard deviation. All measurements were performed at 30 lm concentration of the corresponding pep-




H (r) H (d) S (r) S (d) Trn Unrd
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Bax-a5 Buffer 23 6 15 2 10 2 7 1 19 4 26 3
20% TFE 62 5 26 2 0 1 0 1 3 1 9 6
60% TFE 61 5 27 2 0 1 0 2 1 1 11 5
0.5 mM SDS 63 6 19 3 1 2 0 1 4 4 13 4
4 mM SDS 61 4 25 3 0 1 0 1 4 2 10 6
Bax-a6 Buffer 13 1 10 1 20 4 9 1 20 2 28 3
20% TFE 27 4 15 0.2 8 1 6 0.2 18 2 26 2
60% TFE 40 4 22 2 2 1 3 1 12 3 21 2
0.5 mM SDS 33 3 16 0.2 8 1 5 0.3 15 2 23 3
4 mM SDS 42 1 19 0.3 3 1 2 0.3 11 1 22 1
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lysophospholipids, enhances Bax activity, and the
opposite is observed for lipids with a negative intrinsic
curvature [10,14,15]. Similarly, small percentages of
lysoPtdCho increased the activity of the previously
investigated peptide variant Bax-a5KK, although in
contrast with that observed for the complete protein,
the negatively curved lipid PtdEtn also produces a sig-
nificant increase in peptide activity [28].
For the Bax-a5 and Bax-a6 peptides studied here,
clear increases in calcein release from LUVs were
obtained in the presence of moderate amounts (up to
10%) of lysoPtdCho (Fig. 4A,B and Table 2). The
effect of the nonlamellar lipid PtdEtn follows a
different trend for the two peptides, as summarized in
Table 2. Thus, in the case of Bax-a5, the behaviour is
similar to that reported for the Lys-flanking variant
Bax-a5KK, with small, but consistent, increases in
activity in LUVs containing the nonlamellar lipid.
However, the activity of Bax-a6 is reduced to about
half of the baseline value in the presence of up to 50%
PtdEtn. We assume a comparable binding of the pep-
tides to membranes containing lysoPtdCho and PtdEtn
lipids, with respect to pure PtdCho vesicles, as this has
been shown for melittin, a peptide displaying proper-
ties and a mechanism similar to our Bax peptides [29].
The effects of spontaneous lipid curvature in the
activity of pore-forming peptides are normally used as
evidence in favour of mixed lipid ⁄peptide toroidal
pores, as opposed to barrel-stave pores [16,30]. The
basis of this reasoning is that anisotropic inclusions
are expected to relieve the curvature stress that exists
at the membrane edge of the rim of toroidal pores,
caused by monolayer fusion (Fig. 1). In the case of
purely lipid pores at least, it has been shown experi-
mentally, and modelled theoretically, that cone-shaped
inclusions (with positive spontaneous curvature), such
as detergent molecules, stabilize the pore by reducing
the line tension of the pore rim, whereas inclusions
with negative spontaneous curvature (inverted cone-
shaped) reduce the pore life time by increasing the line
tension [31,32]. However, because of the complex,
saddle-like geometry within the rim of toroidal pores,
negative curvature stress is also expected at the mem-
brane edge in a plane parallel to the bilayer (Fig. 1).
In agreement with this interpretation, a detailed theor-
etical study predicts that saddle-like inclusions, charac-
terized by both positive and negative intrinsic
curvature, favour small pores, whereas wedge-like
inclusions, with only positive curvature, stabilize larger
A
B
Fig. 4. Calcein release from LUVs induced by the Bax-a5 and Bax-
a6 peptides. The percentage calcein release calculated with eqn (1)
is represented as a function of the concentration of added peptide.
(A) shows the effect of Bax-a5, and (B) corresponds to Bax-a6.
Vesicles were prepared with the following compositions: (squares)
egg PtdCho; (circles) PtdCho:lysoPtdCho (90 : 10); (triangles) Ptd-
Cho:PtdSer (50 : 50). Total lipid composition was  6 lM.
Table 2. Effect of the lipid composition of LUVs on the release of
calcein exerted by Bax-a5 and Bax-a6. Lipid mixtures are reported on
a molar basis. 1 ⁄C50 is defined as the inverse concentration of the
particular peptide causing 50% of calcein release. Typical standard
deviations of the reported 1 ⁄C50 values were 8–12%. CL, cardiolipin.
Lipid composition
Activity, 1 ⁄C50 (lM)1)
Bax-a5 Bax-a6
PtdCho 158.7 35.2
PtdCho:PtdSer (75 : 25) 59.3 15.8
PtdCho:PtdSer (50 : 50) 37.6 13.8
PtdCho:CL (90 : 10) 35.3 5.7
PtdCho:lysoPtdCho (95 : 5) 215.1 53.1
PtdCho:lysoPtdCho (90 : 10) 238.1 69.4
PtdCho:PtdEtn (75 : 25) 198.0 28.3
PtdCho:PtdEtn (50 : 50) 175.4 16.3
A. J. Garcı́a-Sáez et al. Large pores formed by Bax peptide fragments
FEBS Journal 273 (2006) 971–981 ª 2006 The Authors Journal compilation ª 2006 FEBS 975
pores [23]. Taking this into account, the increased
poration activity observed for both Bax-a5 and Bax-a6
in the presence of lysoPtdCho indicates that these pep-
tides act by forming toroidal pores. In addition, the
complex heterogeneous effect of PtdEtn may indicate
that these pores are of small to moderate size. A qual-
itative evaluation of this size is described in the next
section.
We should point out that the effects of cardiolipin
and PtdSer (see above), besides their negative charge,
can be also interpreted in terms of their curvature prop-
erties, as these lipids are known to form HII phases
under conditions of reduced interlipid electrostatic
repulsion, as in the presence of Ca2+ or polylysine pep-
tides [33]. Similar conditions could be achieved through
the binding of polycationic Bax-a5 or Bax-a6 peptides,
ending up with the imposition of a negative curvature
strain. However, it is difficult to separate the influence
of curvature from that of the net negative charge of the
lipid, which may inhibit pore formation through alter-
native mechanisms. Thus, a stronger electrostatic inter-
action with negatively charged membranes may affect
the transition of the peptide from an inactive surface-
bound state to a pore-forming state [28,34].
Size of membrane holes made by Bax-a5
and Bax-a6 in LUVs
Pores formed by Bcl2 proteins in the mitochondrial
membrane must be large enough to allow passage of
apoptotic factors stored in the intermembrane space,
such as cytochrome c. It has been shown that Bax,
assisted by tBid, promotes the opening of large lipid
pores, which do not impose a size-exclusion limit for
labelled molecules of mass  0.4–70 kDa [10]. More-
over, Bax accompanied by full-length Bid can promote
the release of dextrans as large as 2000 kDa from pure
synthetic lipid vesicles [35]. We were thus interested in
obtaining an estimate of the size of the pores formed
by the Bax-a5 and Bax-a6 peptide fragments. We
therefore studied the induced release from PtdCho
LUVs of molecules larger than calcein ( 0.6 kDa),
such as 20 kDa and 70 kDa fluorescein-labelled dex-
trans (FD-20 and FD-70, respectively).
As occurred in the case of calcein, dextran release
was markedly dependent on the lipid ⁄peptide (L ⁄P)
molar ratio, but the leakage curves reached a plateau
after a few minutes and complete release was not
achieved for intermediate peptide concentrations
(Fig. 5). This behaviour is common to other amphi-
pathic lytic peptides, such as melittin and magainin,
and it has been explained by an all-or-none mechanism
of release because of the highly co-operative binding of
the peptides to the lipid vesicles [34]. Both Bax-a5 and
Bax-a6 were able to release high-molecular-mass dex-
trans, although, as observed for the experiments with
calcein, Bax-a6 displayed a lower activity than Bax-a5,
and the former needed about three times the concen-
tration of the latter to promote a similar release of
FD-20 or FD-70 (Fig. 5A–D). In contrast, a peptide
A B
C D
Fig. 5. Release of fluorescein-labelled dex-
trans from LUVs. A and B show the time-
dependent release of FD-20 and FD-70,
respectively, from egg PtdCho LUVs as
induced by Bax-a5 at the L ⁄ P molar ratios
indicated on the graphs. C and D show sim-
ilar experiments performed with Bax-a6 at
the L ⁄ P ratios indicated. Arrows indicate the
time at which the corresponding peptides
were added to the vesicle suspension. Lipid
concentration was 45 lM. Release is
expressed as percentage of the activity
observed in the presence of 1 mM Triton
X-100, and calculated with eqn (1).
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976 FEBS Journal 273 (2006) 971–981 ª 2006 The Authors Journal compilation ª 2006 FEBS
corresponding to Bid-a6, which has been shown previ-
ously to be able to release calcein from PtdCho LUVs
[28], assayed at L ⁄P molar ratios up to  5, was
unable to induce the release of FD-20 (not shown).
Before ascribing the increase in fluorescence to the
effect of discrete large membrane pores, other peptide-
mediated effects, such as changes in the distribution
volume through vesicle fusion or vesicle rupture
through partial micellation or detergent-like mecha-
nisms, as described for some antimicrobial peptides
[36], must be considered. These possibilities were tested
by measuring the changes in size of PtdCho LUVs
after treatment with the peptides, using quasi-elastic
light scattering. The results of a few representative
experiments are collected in Table 3. When the peptide
Bax-a5 or Bax-a6 was added at concentrations that
induced a substantial release of dextran, neither the
size distribution of LUVs nor the intensity of the scat-
tered light were affected, indicating that the observed
increase in fluorescence in the experiments on dextran
release is due to neither vesicle rupture nor vesicle
fusion, but rather to peptide-induced membrane pores.
As a positive control of vesicle solubilization, we
added 1 mm Triton X-100, which is the detergent used
to accomplish 100% release of dextrans. Triton X-100
dramatically decreased the intensity of the signal,
which went below the detection limit of our instru-
ment.
A size discrimination of the released molecules was
also noticed, and lower L ⁄P ratios were needed to
achieve a percentage release of FD-70 comparable to
that of FD-20. This indicates that the size of the pores
is dependent on the number of peptides bound per
lipid vesicle. Thus, to a good approximation, for the
range of L ⁄P values used in the experiments of Fig. 5,
we can estimate the upper limit for the radius of pores
made by Bax-a5 and Bax-a6 in PtdCho LUVs to be
5.8 nm, corresponding to the hydrodynamic radius of
70 kDa dextrans [37]. This value is close to the small-
size condition of an ideal toroidal pore for which
negative curvature at the pore rim is expected to be
significant, corresponding to a radius close to half of
the membrane thickness ( 2 nm) [23]. The above des-
cribed heterogeneous effect of PtdEtn on the activity
of Bax-a5 and Bax-a6 is in agreement with the moder-
ate size of pores formed by these peptides. In contrast,
pores made by the concerted action of Bax and tBid,
at a L ⁄P ratio of 1000 [10], should have a bigger
radius, as they were consistently inhibited by negat-
ively curved lipids and exerted no size-exclusion limit
for large dextrans. It is, however, interesting that size
discrimination was observed for pores induced by the
Bax-DC + tBid combination, in which Bax lacks the
C-terminal putative transmembrane helix [10]. This
may indicate a role for the C-terminal helix of Bax in
the formation of large pores, although it may also be
due to the influence of this domain on the efficiency of
membrane insertion.
The pore-forming activity of the Bax fragments is
accompanied by lipid transbilayer redistribution
As we have discussed, the formation of a lipid pore
implies the existence of a membrane edge at the pore
rim where lipids rearrange and tilt to shield their
hydrocarbon chains from the aqueous environment
(Fig. 1). This would effectively fuse the two leaflets of
the membrane allowing fast transbilayer movement of
lipids through lateral diffusion. Thus, fast lipid transbi-
layer redistribution is expected to accompany the for-
mation of toroidal pores by peptides and proteins
[10,20,38]. We have tested this possibility by using an
assay developed by Muller et al. [39]. Briefly, it is
based on the spectral changes observed on redistribu-
tion of the fluorescent PtdCho derivative pyrene
labelled PtdCho (pyPtdCho), initially added to the
external monolayer, to the inner leaflet of the mem-
brane. The incorporation of pyPtdCho to LUVs com-
posed of PtdCho was fast, and the ratio IE ⁄ IM
remained practically constant in the absence of pep-
tides during a time course of 20 min, indicating that
the spontaneous transbilayer diffusion of the fluores-
cent analogue is negligible (not shown). The addition
of Bax-a5 or Bax-a6 at nanomolar concentrations in
the presence of 20 lm lipid induced a rapid decrease in
the IE ⁄ IM ratio, indicating fast transbilayer lipid redis-
tribution (Fig. 6A,B). As a negative control, the
peptide Bid-a6, which forms pores probably of the
barrel-stave type [28], produced no effect on the redis-
tribution of pyPtdCho between the two monolayers
when assayed at L ⁄P ratios as high as 10 (not shown).
Table 3. Effects of Bax-a5, Bax-a6 and Triton X-100 on the size of
PtdCho LUVs. L ⁄ P, Lipid ⁄ peptide molar ratio. Lipid concentration
was 25 lM. Triton X-100 concentration was 1 mM. ND, not detect-
able.





None 0 130.3 ± 1.5 0.11 ± 0.05 141.2 ± 3.6
Bax-a5 500 129.6 ± 1.2 0.12 ± 0.03 147.0 ± 3.5
250 131.4 ± 1.2 0.12 ± 0.03 149.0 ± 4.4
50 140.3 ± 0.9 0.17 ± 0.04 159.6 ± 2.9
Bax-a6 250 130.3 ± 2.3 0.11 ± 0.02 147.4 ± 4.3
125 133.8 ± 2.7 0.16 ± 0.02 149.8 ± 8.6
50 141.3 ± 4.0 0.21 ± 0.07 149.9 ± 9.3
Triton X-100 ND ND 9.5 ± 0.1
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In agreement with the experiments on content
release, we observed that the intrinsic transbilayer redis-
tribution activity was higher in the case of Bax-a5
(Fig. 6A) than for Bax-a6 (Fig. 6B). In both cases, this
activity was observed for concentrations of the same
order of magnitude as that reported for full-length
Bax ⁄ tBid mixtures [10]. In addition, the process of lipid
transbilayer redistribution is induced at L ⁄P ratios
comparable to those needed for the release of dextrans,
and also exhibited a similar time course, which indi-
cates a mechanistic connection between the two obser-
vations. Both the release of high-molecular-mass
dextrans and the increased lipid transbilayer diffusion
on addition of peptides occurred without significantly
affecting the size of the vesicles, excluding the possibil-
ity of a detergent-like action. Such behaviour would be
expected if a mixed lipid ⁄peptide pore with toroidal
structure is being formed, and has also been reported
for the concerted action of Bax and tBid [10].
Concluding remarks
In summary, peptides corresponding to natural
sequences of Bax and encompassing individual helices
of the characteristic a5–a6 hairpin domain can inde-
pendently, and in the absence of tBid, reproduce the
poration activity displayed in vitro by the concerted
action of full-length Bax and tBid. Thus, our results
suggest that Bax possesses, by itself, the intrinsic abil-
ity to form toroidal pores, and this ability is present in
at least two helical fragments of its structure.
Both the a5 and a6 fragments are amphipathic and
have positively charged Lys and ⁄or Arg residues, sim-
ilar to antibiotic peptides such as melittin and magai-
nin, for which the formation of toroidal pores has also
been described. We propose that the ability of Bax to
form pores is inherently linked to the physicochemical
properties of both fragments of the hairpin at least.
Because the actions of the Bax fragments and the full-
length protein are observed at similar concentrations, a
strong synergistic effect of the active fragments in the
context of the whole protein is not expected. Rather,
the complete structure may be important to achieve a
larger pore size, as our data also indicate. Similarly,
other important aspects of the function of Bax, such
as the need to be activated through structural changes,
the concerted action with other proteins such as tBid,
and its oligomerization in the membrane, are certainly
attributes of the whole protein that single fragments
cannot reproduce. These complex aspects allow the
function of Bax to be performed in a regulated man-
ner, modulating the intrinsic poration activity of Bax
fragment sequences to the level required for the correct
functioning of the apoptotic route.
Experimental procedures
Peptide synthesis and purification
Two peptides containing the helices 5 (Bax-a5, Fig. 2C)
and 6 (Bax-a6, Fig. 2D), corresponding to the structure of
a soluble form of Bax, were synthesized chemically. Com-
pared with a previous study [28], the version of Bax-a5
used for this work has been extended at the N-terminus
and contains no extra flanking lysine residues (Fig. 2B,C).
The only difference with respect to the natural sequences
found in mouse Bax is the replacement of Cys126 with Ser
in Bax-a5 to avoid dimerization via disulfide bridges.
A B
Fig. 6. Transbilayer redistribution of pyrene-labelled PtdCho induced by the peptide fragments Bax-a5 and Bax-a6 in LUVs. pyPtdCho was
incorporated into PtdCho LUVs, and the time dependent decrease in IE ⁄ IM induced at different molar L ⁄ P ratios was analysed as described
in Experimental procedures: 200 (diamonds), 500 (triangles down), 1000 (squares), 2000 (circles), and 4000 (triangles up). The arrows indi-
cate when peptides were added to a suspension of egg PtdCho vesicles at a 20 lM lipid concentration. Represented IE ⁄ IM ratios are referred
to the IE ⁄ IM value obtained in the absence of peptides, which is taken as 1.
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Solid-phase synthesis of the peptides was carried out as
reported [28] in an Applied Biosystems (ABI, Foster City,
CA, USA) 433A Peptide synthesizer using Fmoc chemistry
and Tentagel S-RAM resin (Rapp Polymere, Tübingen,
Germany; 0.24 mEq ⁄ g substitution) as a solid support. Pep-
tides were purified using a C18 preparative reversed-phase
column (Merck, Darmstadt, Germany) by HPLC, to a pur-
ity of  95%, and their identity was confirmed by MS. All
peptide concentrations were determined from UV spectra
using a Jasco spectrophotometer (Jasco, Tokyo, Japan).
Preparation and size measurement of vesicles
All lipids used were from Avanti Polar Lipids (Alabaster,
AL, USA). LUVs were prepared as described previously
[40]. Lipids were dissolved in chloroform, mixed to the
desired molar composition, and vacuum-dried to a thin film
on the bottom of a round glass flask. Further drying was
accomplished by 30 min in a strong vacuum. To prepare
the fluorescein-bis(methyliminodiacetic acid) (calcein)-con-
taining LUVs, lipids were resuspended to a concentration
of 4 mgÆmL)1 in a solution containing 80 mm calcein
(Sigma-Aldrich, St Louis, MO, USA), neutralized with
NaOH. After six cycles of freezing and thawing, they were
passed 31 times through two stacked polycarbonate filters
of 100-nm pore size, using a two-syringe extruder from
Avestin (Ottawa, Ontario, Canada). To remove external
nonencapsulated dye, LUVs were filtered on Sephadex
G-50 (Sigma-Aldrich) mini-columns, previously equilibrated
with 140 mm NaCl ⁄ 20 mm Hepes ⁄ 1 mm EDTA, pH 7 (buf-
fer A). In the case of LUVs encapsulated with fluorescent
dextrans (FD-20 or FD-70, from Sigma-Aldrich), the lipid
films were resuspended to a concentration of 10 mgÆmL)1
in a 100 mgÆmL)1 solution of dextrans in buffer A. The ves-
icles were subjected to 20 cycles of freezing and thawing
and extruded as described above, but using 200 nm poly-
carbonate filters. Nonencapsulated dextrans were removed
by gel-filtration chromatography using an ÄKTA system
(Amershan Pharmacia Biotech AB, Uppsala, Sweden) with
a column (35 cm · 1.6 cm) loaded with Sephacryl HS-500
(Amersham), equilibrated with buffer A, at a flow rate of
0.5 mLÆmin)1. Fractions corresponding to the LUVs were
pooled and used in the experiments on content release.
The size of the vesicles was measured by quasi-elastic light
scattering at a fixed angle (90) and room temperature, using
a laser particle sizer (Malvern Z-sizer 3; Malvern, UK)
upgraded with a 30 mW laser diode emitting at 675 nm.
Analysis of the autocorrelation function allows the estima-
tion of the diffusion coefficient of the particles through
Laplace inversion, from which the hydrodynamic radius is
calculated using the cumulant method [41] and the Stokes-
Einstein equation. The lipid concentration was estimated
with the Phospholipids B kit (Wako Chemicals GmbH,
Neuss, Germany), following the supplier’s protocol.
Permeabilization of LUVs
The permeabilizing activity of the peptides was assayed by
measuring the release of the fluorescent probes calcein or
fluorescein-labelled dextrans from LUVs. Release of the
entrapped probe at self-quenching concentrations was mon-
itored as an increase in the fluorescence intensity with time,
due to dilution to nonquenching concentrations as the dye
mixes with the external solution. Experiments on calcein
release were performed using a 96-well microtitre plate
filled with 100 lL buffer A containing the desired amount
of peptide. To avoid unspecific interactions of the peptides
and vesicles with the plastic walls, the microplates were pre-
treated with a 0.1 mgÆmL)1 Prionex (Pentapharm, Basel,
Switzerland) solution for 30 min. All experiments were car-
ried out at room temperature. After the addition of 100 lL
LUVs, at a final lipid concentration of 2–5 lgÆmL)1, the
time course of calcein release was measured as the increase
in fluorescence emission at 520 nm with the excitation set
at 495 nm, using a fluorescence microplate reader (FLUO-
star; BMG Labtech GmbH, Offenburg, Germany). The
experiments measuring release of fluorescent dextrans were
carried out using a cell of 1-cm path length in an LS-50B
luminescence spectrometer (Perkin Elmer, Boston, MA,
USA). The desired amount of peptide was added to the
reaction mixture containing 1 mL buffer A and 100 lL
LUVs (at a final lipid concentration of 45 lm). The increase
in fluorescence intensity at 520 nm (with excitation wave-
length set at 490 nm, and emission band slits at 2 nm) due
to the release kinetics was monitored until the stationary
state was reached.
The percentage of peptide-induced dye release (%R) was
calculated from:
%R ¼ 100½ðFf  FiÞ=ðFm  FiÞ ð1Þ
where Ff is fluorescence measured in the stationary state
(after 1 h incubation for calcein release and 12.5 min for
release of dextrans), Fi is the initial fluorescence before the
addition of the peptides, and Fm is the maximal value after
addition of 1 mm Triton X-100. Spontaneous release of
calcein or dextrans was found to be negligible in all cases.
Lipid transbilayer diffusion in LUVs
Asymmetrically labelled vesicles were prepared as described
[39]. The desired amount of 1-lauroyl-2-(1¢-pyrenebutyroyl)-
sn-glycero-3-phosphocholine (py-PtdCho) from a chloro-
form stock was dried on a glass tube with a nitrogen flux
and dissolved in ethanol at the desired concentration. The
fluorescent probe in ethanol solution was added to a final
concentration of 1 lm to buffer A. Then LUVs prepared as
described above, but rehydrated in buffer A, were added to
a final lipid concentration of 20 lm. Under these conditions,
the labelled lipid is incorporated only into the external
A. J. Garcı́a-Sáez et al. Large pores formed by Bax peptide fragments
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leaflet of LUVs. Fluorescence emission spectra between 355
and 500 nm were recorded at room temperature with excita-
tion set at 345 nm, using an LS-50B luminescence spectro-
meter (Perkin Elmer) and a 1-cm path-length cell with
constant stirring. Emission intensities of the excimers (IE at
465 nm) and the monomers (IM at 395 nm) were taken from
the spectra to compute IE ⁄ IM ratios. After incubation for
20 min, to ensure stability, the peptide was added and val-
ues of IE ⁄ IM, related to the corresponding emission ratios in
the absence of peptides, were plotted against time.
CD spectroscopy
Samples for CD spectroscopy were prepared at a 30 lm
concentration of peptide in 10 mm phosphate buffer at
pH 7. Several percentages of trifluoroethanol, or different
concentrations of SDS, below and above the critical micel-
lar concentration, were added to the corresponding sam-
ples. Spectra were measured at 20 C on a Jasco J-810 CD
spectropolarimeter, using a cell of 1 mm path length. The
data were collected every 0.2 nm at 100 nmÆmin)1 from 250
to 185 nm, with a bandwidth of 1 nm, and results were
averaged from 10 scans.
Data were analysed with the help of the CDPro software
package, which contains three commonly used programs:
selcon3, contin ⁄ ll and cdsstr [42,43]. This software
allows the use of different reference sets of proteins, including
membrane proteins, increasing the reliability of the analysis.
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